Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival-Reference-Cited by-同舟云学术

Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival

Published:2014-01 Issue:1 Volume:88 Page:87-93
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Lo Andrea C.,Morris W. James,Lapointe Vincent,Hamm Jeremy,Keyes Mira,Pickles Tom,McKenzie Michael,Spadinger Ingrid

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference28 articles.

3. Post-treatment PSA;Critz;Urology,1999

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. An Updated Analysis of the Survival Endpoints of ASCENDE-RT;International Journal of Radiation Oncology*Biology*Physics;2023-04